Matches in SemOpenAlex for { <https://semopenalex.org/work/W4362541105> ?p ?o ?g. }
- W4362541105 endingPage "1201" @default.
- W4362541105 startingPage "1201" @default.
- W4362541105 abstract "Abstract Purpose: Anaplastic Lymphoma Kinase (ALK) aberrations have been identified in pediatric type infant gliomas, but their occurrence across age groups, functional effects, and treatment response have not been broadly established. Experimental Design: We performed a comprehensive analysis of ALK expression and genomic aberrations in both newly-generated and retrospective data from 371 glioblastomas (156 adult, 205 infant/pediatric and 10 congenital) with in vitro and in vivo validation of aberrations. Results: ALK aberrations at the protein or genomic level were detected in 12% of gliomas (45/371) in a wide age range (0-80 years). Recurrent as well as novel ALK fusions (LRRFIP1-ALK, DCTN1-ALK, PRKD3-ALK) were present in 50% (5/10) of congenital/infant, 1.4% (3/205) of pediatric, and 1.9% (3/156) of adult GBMs. ALK fusions were present as the only candidate driver in congenital/infant GBMs, and were sometimes focally amplified. In contrast, adult ALK fusions co-occurred with other oncogenic drivers. No activating ALK mutations were identified in any age group. Novel and recurrent ALK rearrangements promoted STAT3 and ERK1/2 pathways and transformation in vitro and in vivo. ALK-fused GBM cellular and mouse models were responsive to ALK inhibitors, including in patient cells derived from a congenital GBM. Relevant to treatment of infant gliomas, we showed that ALK protein appears minimally expressed in the forebrain at perinatal stages and no gross effects on perinatal brain development was seen in pregnant mice treated with the ALK inhibitor ceritinib. Conclusions: These findings support expanded evaluation of brain-penetrant ALK inhibitors in clinical trials across infant, pediatric, and adult GBMs. Citation Format: Anne-Florence Blandin, Ross Giglio, Maya Srikanth Graham, Guadalupe Garcia, Seth Malinowski, Jared K. Woods, Shakti Ramkissoon, Lori Ramkissoon, Frank Dubois, Kate Schoolcraft, Jessica W. Tsai, Dayle K. Wang, Robert Jones, Jayne Vogelzang, Kristine Pelton, Sarah Becker, Fiona Watkinson, Claire Sinai, Elizabeth Cohen, Matthew Booker, Michael Tolstorukov, Veerle Haemels, Liliana Goumnerova, Karen Wright, Mark Kieran, Katie Fehnel, David Reardon, Arnault Tauziede-Espariat, Rishi Lulla, Benjamin Carcamo, Stanley Chaleff, Alain Charest, Frederik De Smet, Azra H. Ligon, Adrian Dubuc, Melanie Pagès, Pascale Varlet, Patrick Wen, Brian Alexander, Susan Chi, Sanda Alexandrescu, Ralf Kittler, Robert Bachoo, Rameen Beroukhim, Pratiti Bandopadhayay, Keith L. Ligon. ALK amplification and rearrangements are recurrent targetable events in congenital and adult glioblastoma [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 1201." @default.
- W4362541105 created "2023-04-06" @default.
- W4362541105 creator A5001355914 @default.
- W4362541105 creator A5004402830 @default.
- W4362541105 creator A5010270402 @default.
- W4362541105 creator A5011987033 @default.
- W4362541105 creator A5012992077 @default.
- W4362541105 creator A5021656597 @default.
- W4362541105 creator A5022157157 @default.
- W4362541105 creator A5022385078 @default.
- W4362541105 creator A5024876144 @default.
- W4362541105 creator A5026339662 @default.
- W4362541105 creator A5027575883 @default.
- W4362541105 creator A5032098479 @default.
- W4362541105 creator A5034760960 @default.
- W4362541105 creator A5037228057 @default.
- W4362541105 creator A5038992066 @default.
- W4362541105 creator A5039022911 @default.
- W4362541105 creator A5041980697 @default.
- W4362541105 creator A5043153075 @default.
- W4362541105 creator A5044684517 @default.
- W4362541105 creator A5044869256 @default.
- W4362541105 creator A5045184874 @default.
- W4362541105 creator A5046557285 @default.
- W4362541105 creator A5047888321 @default.
- W4362541105 creator A5049957915 @default.
- W4362541105 creator A5051462497 @default.
- W4362541105 creator A5054071842 @default.
- W4362541105 creator A5056099258 @default.
- W4362541105 creator A5056581996 @default.
- W4362541105 creator A5059965175 @default.
- W4362541105 creator A5060208068 @default.
- W4362541105 creator A5060358208 @default.
- W4362541105 creator A5061990450 @default.
- W4362541105 creator A5063515630 @default.
- W4362541105 creator A5063572228 @default.
- W4362541105 creator A5065891037 @default.
- W4362541105 creator A5066878975 @default.
- W4362541105 creator A5067542863 @default.
- W4362541105 creator A5068793931 @default.
- W4362541105 creator A5077011745 @default.
- W4362541105 creator A5084589096 @default.
- W4362541105 creator A5085626192 @default.
- W4362541105 creator A5087534739 @default.
- W4362541105 creator A5088254403 @default.
- W4362541105 creator A5090417424 @default.
- W4362541105 creator A5090423495 @default.
- W4362541105 creator A5091809423 @default.
- W4362541105 date "2023-04-04" @default.
- W4362541105 modified "2023-10-15" @default.
- W4362541105 title "Abstract 1201: <i>ALK</i> amplification and rearrangements are recurrent targetable events in congenital and adult glioblastoma" @default.
- W4362541105 doi "https://doi.org/10.1158/1538-7445.am2023-1201" @default.
- W4362541105 hasPublicationYear "2023" @default.
- W4362541105 type Work @default.
- W4362541105 citedByCount "0" @default.
- W4362541105 crossrefType "journal-article" @default.
- W4362541105 hasAuthorship W4362541105A5001355914 @default.
- W4362541105 hasAuthorship W4362541105A5004402830 @default.
- W4362541105 hasAuthorship W4362541105A5010270402 @default.
- W4362541105 hasAuthorship W4362541105A5011987033 @default.
- W4362541105 hasAuthorship W4362541105A5012992077 @default.
- W4362541105 hasAuthorship W4362541105A5021656597 @default.
- W4362541105 hasAuthorship W4362541105A5022157157 @default.
- W4362541105 hasAuthorship W4362541105A5022385078 @default.
- W4362541105 hasAuthorship W4362541105A5024876144 @default.
- W4362541105 hasAuthorship W4362541105A5026339662 @default.
- W4362541105 hasAuthorship W4362541105A5027575883 @default.
- W4362541105 hasAuthorship W4362541105A5032098479 @default.
- W4362541105 hasAuthorship W4362541105A5034760960 @default.
- W4362541105 hasAuthorship W4362541105A5037228057 @default.
- W4362541105 hasAuthorship W4362541105A5038992066 @default.
- W4362541105 hasAuthorship W4362541105A5039022911 @default.
- W4362541105 hasAuthorship W4362541105A5041980697 @default.
- W4362541105 hasAuthorship W4362541105A5043153075 @default.
- W4362541105 hasAuthorship W4362541105A5044684517 @default.
- W4362541105 hasAuthorship W4362541105A5044869256 @default.
- W4362541105 hasAuthorship W4362541105A5045184874 @default.
- W4362541105 hasAuthorship W4362541105A5046557285 @default.
- W4362541105 hasAuthorship W4362541105A5047888321 @default.
- W4362541105 hasAuthorship W4362541105A5049957915 @default.
- W4362541105 hasAuthorship W4362541105A5051462497 @default.
- W4362541105 hasAuthorship W4362541105A5054071842 @default.
- W4362541105 hasAuthorship W4362541105A5056099258 @default.
- W4362541105 hasAuthorship W4362541105A5056581996 @default.
- W4362541105 hasAuthorship W4362541105A5059965175 @default.
- W4362541105 hasAuthorship W4362541105A5060208068 @default.
- W4362541105 hasAuthorship W4362541105A5060358208 @default.
- W4362541105 hasAuthorship W4362541105A5061990450 @default.
- W4362541105 hasAuthorship W4362541105A5063515630 @default.
- W4362541105 hasAuthorship W4362541105A5063572228 @default.
- W4362541105 hasAuthorship W4362541105A5065891037 @default.
- W4362541105 hasAuthorship W4362541105A5066878975 @default.
- W4362541105 hasAuthorship W4362541105A5067542863 @default.
- W4362541105 hasAuthorship W4362541105A5068793931 @default.
- W4362541105 hasAuthorship W4362541105A5077011745 @default.
- W4362541105 hasAuthorship W4362541105A5084589096 @default.
- W4362541105 hasAuthorship W4362541105A5085626192 @default.
- W4362541105 hasAuthorship W4362541105A5087534739 @default.